USA: 
Europe: 
Email: 
Consultation
| Catalog: | C1310T |
| Product Type: | Test kit |
| Unit: | 96 tests |
| Tested parameter: | amyloid beta |
| Sample type: | cerebrospinal fluid |
| Test type: | quantitative |
| Analysis mode: | enzyme immunoassay |
| Application: | neurodegenerative diseases |
The test is a solid-phase enzyme immunoassay for the quantitative determination of β-amyloid in human cerebrospinal fluid (CSF). The combined use of CSF-Tau and CSF-β-amyloid marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression.
Diagnostic Development
Follow Us -
Copyright © 2024 Creative Bioarray. All rights reserved.
